Clinical Trials Directory

Trials / Completed

CompletedNCT04908605

Emergence Agitation After Nasal Surgery: a Randomized Controlled Comparison Between Melatonin and Mirtazapine

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
165 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
21 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Emergence agitation (EA) is common after nasal surgery under general anesthesia, which can lead to several problems, such as increased risk of injury to the patient or medical staff, pain, decreased patient satisfaction, hemorrhage, re-bleeding at the operation site and unplanned self-extubation. Melatonin is an oral or sublingual medication, most commonly used for insomnia and improving sleep in different conditions for example shift-work disorder and for helping people to establish a day and night cycle especially blind children or adults. Mirtazapine is an antidepressant used in medicine in a pill form, most commonly used for major depressive disorder and other mood disorders, relief of anxiety, panic disorders, insomnia, headache and migraine.

Conditions

Interventions

TypeNameDescription
DRUGMirtazapineEvery patient will be given mirtazapine 30 mg tablet
DRUGMelatoninEvery patient will be given melatonin 5 mg tablet
DRUGPlaceboEvery patient will be given a matching placebo tablet

Timeline

Start date
2021-06-15
Primary completion
2022-03-31
Completion
2022-03-31
First posted
2021-06-01
Last updated
2022-04-15

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04908605. Inclusion in this directory is not an endorsement.